Join us for three new workshops on next-generation sequencing for clinical research. Researchers from leading clinical research laboratories will discuss workflows and present data showing targeted detection of specific genes and mutations using limited solid and liquid tumor research samples, and infectious disease research. AMP attendees, and the public at-large, may attend all three sessions at no additional charge. 

November 4, Austin Convention Center, Grand Ballroom D, Level 4

8:00 AM—Oncology Solid Tumor Profiling

Expand your results from FFPE solid tumor samples with Ion Torrent Oncomine next-generation sequencing (NGS) assays 

Ion Torrent™ Oncomine™ NGS assays are multibiomarker oncology assays that allow for concurrent analysis of DNA and RNA in a single workflow, enabling simultaneous detection of single-nucliotide variants, indels, copy number variants and gene fusions. Providing a unique opportunity to help reduce the time and complexity of molecular tumor profiling, this workshop will include presentation from leading clinical research laboratories demonstrating the performance and application of these assays with FFPE solid tumor samples and fine-needle aspirates. 

9:00 AM—Liquid Biopsy Clinical Research for Oncology

Advanced Ion Torrent™ next-generation sequencing and Applied Biosystems™ digital PCR applications to analyze liquid biopsy samples in today’s laboratory.

Significant progress has been made in development of new molecular methods to unlock the potential of circulating tumor cells (CTCs) and cell-free DNA (cfDNA) from liquid biopsy samples. This emerging method also provides a potential future alternative approach to monitoring therapy response and recurrence, with the possibility to overcome many of the limitations associated with obtaining tumor samples today. Join us in this workshop where researchers from leading clinical laboratories will discuss advanced molecular profiling methods for both CTCs and cfDNA using NGS and digital PCR, key considerations for implementation and prospects for the future.

10:00 AM—Infectious Disease

Molecular profiling in infectious disease research using high-throughput Applied Biosystems™ real-time PCR and Ion Torrent next-generation sequencing

The use of high-throughput genomic technologies such as NGS and real-time PCR has rapidly increased our knowledge in the identification and evolution of infectious disease agents, which may improve the future of health care. Join this workshop to hear researchers from leading laboratories present results on how they are maximizing the targeted detection of specific genes to enable efficient identification of microbes within mixed populations, perform research on retrospective outbreak samples and discover mutations that may be associated with antibiotic resistance. 

For Research Use Only. Not for use in diagnostic procedures.